Picture of Lees Pharmaceutical Holdings logo

950 Lees Pharmaceutical Holdings Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapContrarian

Annual cashflow statement for Lees Pharmaceutical Holdings, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
HKAS
HKAS
HKAS
HKAS
HKAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line1,96967.930.898.172.9
Depreciation
Amortisation
Non-Cash Items-1,90271.628.170.573.8
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-3.45-8.36-98.3-74.430.6
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Other Operating Cash Flow
Cash from Operating Activities211284110242333
Capital Expenditures-371-214-160-208-232
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.443-42.214.517.3-4.21
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-370-256-145-190-236
Financing Cash Flow Items0
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities61-12913.4-1.9635.6
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-97.7-88.2-21.849.3129